Mental Disorders

Higher Ultraprocessed Food Intake Linked to Increased Dementia Risk

A nationally representative study of 5,370 older US adults found that higher consumption of ultraprocessed foods (UPFs) was associated with significantly increased risks of dementia, cognitive impairment without dementia (CIND), and the combined outcome of CIND or dementia. Researchers analyzed data from the Health and Retirement Study between 2013 and 2020, using dietary information collected through a food frequency questionnaire and cognitive status determined through validated biennial assessments. Compared with participants in the lowest quintile of UPF intake, those in the highest quintile had a 58% higher risk of developing dementia (HR 1.58), a 46% higher risk of CIND (HR 1.46), and a 47% higher risk of experiencing either CIND or dementia (HR 1.47). In contrast, greater consumption of unprocessed or minimally processed foods was associated with lower risks of cognitive impairment and dementia. These findings suggest that diets high in UPF may contribute to cognitive decline in later life and support public health efforts to reduce UPF consumption as a potential strategy for preserving brain health among older adults. UPF intake has already been associated with increased risks for cardiovascular disease, diabetes, cancers, and obesity, etc. Source: https://ajph.aphapublications.org/

hyangiu

Recent Posts

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

20 hours ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

20 hours ago

Stopping Statins Noninferior to Continuing Them in Older Adults without Known CVD

Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing…

22 hours ago

Ziltivekimab and Pelacarsen Show No Clinical Benefit Despite Effective Biomarker Lowering

Two randomized, placebo-controlled trials of targeted therapies—ziltivekimab, a monoclonal antibody neutralizing interleukin-6, and pelacarsen, an…

2 days ago

Cold Drives Heart Failure Hospitalizations in Older US Adults

Among US Medicare beneficiaries, colder ambient temperatures were associated with increased heart failure hospitalizations while…

6 days ago

No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up

In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary…

6 days ago

This website uses cookies.